Last reviewed · How we verify

NCT06978127: TACcare 2 0

Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients

Recruiting now NA Last updated 2 February 2026
What this trial tests

NA trial testing Technology Assisted Stepped Collaborative Care in Chronic Kidney Disease Requiring Hemodialysis in 424 participants. Currently enrolling.

Timeline
28 August 2025
Primary endpoint
30 June 2029
30 June 2029

Quick facts

Lead sponsorUniversity of Pittsburgh
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment424
Start date28 August 2025
Primary completion30 June 2029
Estimated completion30 June 2029
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Pittsburgh

Who can join

18 and older, any sex, with Chronic Kidney Disease Requiring Hemodialysis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to learn if a collaborative care intervention of pharmaco-therapy and/or cognitive behavioral therapy (CBT), delivered in a real-world setting, improves symptoms of pain, fatigue and/or depression.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Kidney Disease Requiring Hemodialysis

Currently open trials in the same condition.

Other University of Pittsburgh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06978127.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing